Apostolos Zaravinos.

Dr Apostolos Zaravinos is a Professor of Cancer Genetics at the European University of Cyprus, and the group leader of the “Cancer Genetics, Genomics & Systems Biology” Group of the Basic and Translational Cancer Research Center (BTCRC). He received his BSc in Biology from the Department of Biology, University of Crete, and his PhD in Medicine from the Medical School of the same University. He worked as a Research Scientist at the harris Birthright Research Center for Fetal Medicine, King’s College Hospital, and performed postdoctoral research in Cancer Genetics at the Molecular Medicine Research Center, University of Cyprus. He completed his postdoctoral training in Immunogenetics and Cancer Genetics at the Department of Laboratory Medicine, Karolinska Institute. In addition, he worked as an associate Professor in Genetics in the Department of Basic Medical Science, at the College of Medicine, Qatar University.

Dr Zaravinos holds two Specialisations: one in “Systems Biology” from the Systems Biology Center at Icahn School of Medicine, Mount Sinai, and another in “Genomic Data Science” from the McKusick-Nathans Institute of Genetic Medicine, John Hopkins University. He is a member of the Editorial Board of BMC Cancer, International Journal of Molecular Sciences, Frontiers in Oncology, and Frontiers in Pharmacology, among others. Since 2020 he has been included each year in the list of the top 2% of the world’s most cited and influential scientists, according to Stanford University. He is the recipient of the “Distinguished Researcher Award – 2022” from the European University Cyprus, the “1st Young Investigator Award – 2017” from the Bank of Cyprus Oncology centre, and the “Science Award – 2016” from the Youth Board of Cyprus.

He is a member of the EACR, AACR, and FEBS, and the newly-elected vice chair of the Society of Biological Sciences in Cyprus board. He has published >120 papers in refereed journals and 7 book chapters. His research work aims toward the advanced understanding of carcinogenesis through the investigation of interactions across genes, the discovery of therapeutic targets, and the examination of the immune landscape in inflamed tumors.